Background: Metformin has long been used for glycemic control in diabetic state. Recently, other benefits of metformin beyond blood glucose regulation have emerged. Objectives: To investigate the effect of metformin on the expression of testicular steroidogenesis-related genes, spermatogenesis, and fertility of male diabetic rats. Materials and methods: Eighteen adult male Sprague Dawley rats were divided into three groups, namely normal control (NC), diabetic control (DC), and metformin-treated (300 mg/kg body weight/day) diabetic rats (D+Met). Diabetes was induced using a single intraperitoneal injection of streptozotocin (60 mg/kg b.w.), followed by oral treatment with metformin for four weeks. Results: Diabetes decreased serum and intratesticular testosterone levels and increased serum but not intratesticular levels of luteinizing hormone. Sperm count, motility, viability, and normal morphology were decreased, while sperm nuclear DNA fragmentation was increased in DC group, relative to NC group. Testicular mRNA levels of androgen receptor, luteinizing hormone receptor, cytochrome P450 enzyme (CYP11A1), steroidogenic acute regulatory (StAR) protein, 3b-hydroxysteroid dehydrogenase (HSD), and 17b-HSD, as well as the level of StAR protein and activities of CYP11A1, 3b-HSD, and 17b-HSD, were decreased in DC group. Similarly, decreased activities of epididymal antioxidant enzymes and increased lipid peroxidation were observed in DC group. Consequently, decreased litter size, fetal weight, mating and fertility indices, and increased pre-and post-implantation losses were recorded in DC group. Following intervention with metformin, we observed increases in serum and intratesticular testosterone levels, Leydig cell count, improved sperm parameters, and decreased sperm nuclear DNA fragmentation. Furthermore, mRNA levels and activities of steroidogenesis-related enzymes were increased, with improved fertility outcome. Discussion and conclusion: Diabetes mellitus is associated with dysregulation of steroidogenesis, abnormal spermatogenesis, and fertility decline. Controlling hyperglycemia is therefore crucial in preserving male reproductive function. Metformin not only regulates blood glucose level, but also preserves male fertility in diabetic state.
INTRODUCTION
Diabetes mellitus (DM) is a metabolic disease that affects the normal functioning of several body systems as a result of abnormal energy metabolism and oxidative stress, which are known to accompany the disease. The global prevalence of DM was reported by the International Diabetes Federation (IDF) to be 415 million in 2015 (Ogurtsova et al., 2017) . Recent estimates showed a prevalence of 425 million among adults aged 20-79 years in 2017, representing 8.8% of the world's population, with a projected 629 million of the same age-group by 2045, representing 9.9% of the world's population (Cho et al., 2018) . These reports point to an alarming prevalence of DM among individuals of reproductive age.sperm abnormal morphology, DNA fragmentation, and reduced fertility potential have all been reported in DM (Karimi et al., 2012; Ding et al., 2016; Reddy et al., 2016; Joshi et al., 2017) . These negative effects have been linked to oxidative stress, which accompanies the disease (Vignera et al., 2012) . There are conflicting reports on the impact of DM on gonadotropic hormones. For example, significant decreases in serum gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) have been reported , while others reported increases in FSH and LH levels in diabetic rats (Himabindu et al., 2015; S€ onmez et al., 2015) . DM increases testicular concentration of cholesterol, the precursor for androgen synthesis (Saumya & Basha, 2017) . DM also decreases the transcript level of steroidogenic acute regulatory protein (StAR) (Nah et al., 2012; Liu et al., 2016; Joshi et al., 2017) and cytochrome P450 cholesterol side-chain cleavage enzyme (P450 SCC ; CYP11A1) activity (Ding et al., 2016; Joshi et al., 2017) , both of which constitute the rate-limiting step in steroidogenesis. However, the transcript level of StAR was reported to increase in rats after 12 weeks of DM induction (Ding et al., 2016) . Furthermore, decreases in the activities of 3b-hydroxysteroid dehydrogenase (HSD) and 17b-HSD, with accompanying decrease in testosterone level, have been reported in DM (Reddy et al., 2016) . Although there are conflicting reports on the effect of DM on gonadotropic hormones, as well as the mechanism of DM-induced suppression of steroidogenesis, reduced testosterone level has been consistently reported in both experimental (Reddy et al., 2016; Lin et al., 2017) and human (Dhindsa et al., 2010; Bansal et al., 2017; Rovira-Llopis et al., 2017) studies of types I and II DM.
Metformin, an antihyperglycemic medication, is used to regulate blood glucose, especially in type II DM. Its mechanisms of action in lowering blood glucose level involves reduction in intestinal glucose absorption, inhibition of hepatic gluconeogenesis, increase in insulin sensitivity, and increase in glucose uptake in peripheral tissues (Zhou et al., 2001; Sakar et al., 2010; Martineau, 2012) . Beyond the management of DM, several beneficial roles of metformin have emerged. For example, metformin and clomifene are currently being prescribed for females for the management of polycystic ovarian syndrome (PCOS), with positive results (Palomba et al., 2014) . Also, experimental studies have found metformin beneficial in protecting the hippocampus (Ge et al., 2017) , heart (Apaijai et al., 2014) , and testis (Asghari et al., 2016; Ghasemnejad-Berenji et al., 2018) from ischemiareperfusion injury. It also increases androgen and estrogen receptor expressions in the testis and increases serum testosterone level in diabetic rats (Nasrolahi et al., 2013; Ayuob et al., 2015) . However, the mechanism through which metformin preserves steroidogenesis in male diabetics, which is crucial for procreation, has not been fully investigated. The aim of this study therefore was to determine the effects of metformin on sperm parameters, the expression of steroidogenesis-related genes, epididymal oxidative stress status, histology, and fertility potential of diabetic rats.
MATERIALS AND METHODS

Materials
Streptozotocin (STZ), acridine orange, agarose, and RNAlater were purchased from Sigma-Aldrich (USA). Metformin used in this study was purchased from Hovid Bhd, Malaysia. ELISA kits for testosterone, FSH, LH, StAR protein, CYP11A1, 3b-HSD, and 17b-HSD were purchased from Shanghai Qayee (China). InnuPrep RNA mini kit was purchased from Analytik Jena (Germany), SensiFAST SYBR Hi-ROX One-Step PCR kit was purchased from Bioline (United Kingdom), primers were obtained from Integrated DNA Technologies (IDT, Malaysia), and the PCR tubes and strips were purchased from Applied Biosystems (Life Technologies, China). All other chemicals were of analytical grade.
Laboratory animals
Eighteen (18) adult male and thirty-six (36) sexually mature female Sprague Dawley rats aged 10 weeks and weighing 250-300 g were used for the present study. The rats were obtained from the Animal Research and Service Centre, Universiti Sains Malaysia (USM), Kelantan, Malaysia, and kept in the Animal Room, Department of Physiology, School of Medical Sciences, USM, at room temperature (23 AE 2°C). The rats were maintained in 12/12-h reversed light/dark cycle, with lights on from 12:00 to 24:00 h, with ad libitum access to standard pellet diet and drinking water. They were kept for 7 days for habituation before commencement of the study. This research protocol was approved by USM animal ethics committee [USM/IACUC/2017/ (831)], and the rats were handled in accordance with the Guidelines for the Care and Use of Laboratory Animals by the National Institute of Health.
Experimental design
The male rats were randomly assigned into three groups (n = 6/group), namely normal control (NC), diabetic control group (DC), and diabetic group treated with metformin (D+Met). Metformin was orally administered in a volume of 1 mL of distilled water (vehicle) at a dose of 300 mg/kg body weight per day (La Fontaine et al., 2016) . The NC and DC groups received 1 mL of the vehicle per day. Treatment lasted for 4 weeks, during which the rats were monitored for progression or regression of DM. Fasting blood glucose (FBG) level and body weight were measured weekly. The animals were sacrificed under pentobarbital anesthesia (60 mg/kg body weight) after 4 weeks of treatment.
Induction of type 1 diabetes mellitus
After an overnight fast, diabetes was induced using STZ (60 mg/kg body weight, i.p.) dissolved in ice-cold saline (Pushparaj et al., 2001; Nna et al., 2018) . The drinking water of each rat was replaced with 5% glucose solution provided ad libitum overnight post-STZ injection, to prevent STZ-induced hypoglycemia and mortality. Diabetes was confirmed 72 h after STZ injection, and rats with FBG ≥ 14 mmol/L measured using a glucometer (URight TD-4279 Blood Glucose Monitoring System, Germany) were selected for the current study.
Fertility assessment
After 3 weeks of treatment, each male rat was paired with two proven fertile female rats at estrous phase. The female rats were first screened for two consecutively regular estrous cycles, before pairing with the male rats. They were paired for 3 h per day (9:00 h-12:00 h) during the dark phase of the reversed light/dark cycle. After the mating period, vaginal smear was examined under a light microscope (Olympus BX41, Olympus Corporation, Tokyo, Japan) for the presence of spermatozoa. A spermatozoon-positive vaginal smear confirmed mating, and that day was recorded as day 0 of pregnancy (Kuriyama et al., 2005; Mohamed et al., 2013) . A male rat was considered unable to mate if no mating was recorded after three attempts. The pregnant female rats were sacrificed on day 21 of pregnancy, and the following parameters were assessed for male reproductive performance: (i) gravid uterine weight, (ii) litter size per dam, (iii) fetal weight, (iv) number of implantation sites, (v) number of corpora luteal, (vi) pre-implantation loss (number of corpora lutea À number of implantation sites)/(number of corpora lutea) 9 100, (vii) postimplantation loss (number of implantation sites À number of fetuses)/(number of implantation sites) 9 100, (viii) mating index (number mated/number paired) 9 100, and (ix) fertility index (number of pregnant females/number paired) 9 100.
Sample collection
Following sacrifice, blood samples were collected into plain tubes and allowed to stand for 2 h, followed by centrifugation at 4000 rpm for 15 min. Serum was obtained and stored at À80°C until use. The left testis was rinsed in ice-cold saline and divided into two portions; one portion was fixed in RNAlater and stored at À80°C until use. From the second portion, 10% homogenate was prepared. Also, 10% homogenate of the left caput epididymis was prepared. Briefly, the samples were weighed and homogenized in ice-cold Tris-HCl buffer (pH 7.4), centrifuged at 1,000 g for 20 min using a refrigerated centrifuge, and the supernatant was obtained and stored at À80°C until use.
Sperm analysis
Sperm motility was assessed using Makler's counting chamber (Sefi-Medical Instruments, Israel) as previously reported (Mohamed et al., 2011a) with some modifications. Briefly, the left vas deferens of each rat was removed and its content was gently squeezed into 1 mL of normal saline and gently stirred. One drop of the sperm suspension was then placed on the mounting stage of the counting chamber and viewed under a light microscope (Olympus BX41). The number of motile spermatozoa was counted in 10 random fields, and the result was expressed as a percentage of the total number of spermatozoa in the same fields.
Sperm count was assessed as previously reported (Mohamed et al., 2011a) with minor modifications. Briefly, the left cauda epididymis was minced in 2 mL of normal saline and filtered using a nylon mesh, and the filtrate (sperm suspension) was stained with eosin. The stained sperm suspension was then transferred to both chambers of a Neubauer hemocytometer (Hawksley, England). Sperm heads were counted in five squares of each chamber of the hemocytometer under a light microscope using routine counting techniques. For sperm viability, the stained sperm suspension was smeared on a glass slide, covered with a coverslip, and viewed under a microscope using 100x objective. Sperm heads which stained pink were non-viable, while unstained sperm heads were viable. The number of viable spermatozoa was counted in 200 spermatozoa and expressed as a percentage of the total spermatozoa counted (Nna & Osim, 2017) . To assess sperm morphology, the smear was examined for the presence of spermatozoa abnormalities such as head and tail defects. For each slide, 200 spermatozoa were counted, and the number of defective spermatozoa was expressed in percentage (Mohamed et al., 2011a; Nna & Osim, 2017) .
Acridine orange staining for sperm nDNA fragmentation Sperm smear was made on a glass slide, air-dried at room temperature for 1 h, and fixed in Carnoy's solution (methanol/ glacial acetic acid, 3 : 1) for 2 h at 4°C. Thereafter, it was stained for 10 min in freshly prepared acridine orange (0.19 mg/mL in Mcllvain phosphate-citrate buffer, pH 4.0). The smear was then examined under a fluorescent microscope (Olympus BX41) with a 460-nm filter (Pourentezari et al., 2016) . For each rat, two slides were stained, and the number of spermatozoa with fragmented nDNA (orange-red fluorescence) was counted in 100 spermatozoa/field.
Measurement of serum and intratesticular levels of reproductive hormones
Serum and testis homogenate were used for assessment of testosterone, FSH, and LH levels using commercially available ELISA kits (Shanghai Qayee, China), following the manufacturer's protocols.
Epididymal oxidative stress assessment
The epididymal tissue homogenate was used for oxidative stress assessment. Superoxide dismutase (SOD) activity was assessed using a method based on nitro tetrazolium blue reduction (Al Batran et al., 2013) . Catalase (CAT) activity was assessed based on enzyme-catalyzed decomposition of hydrogen peroxide, which forms a yellowish complex with molybdate (Chandran et al., 2014) . Glutathione peroxidase (GPx) activity was assessed following a previously described method, which is based on oxidation of glutathione by hydrogen peroxide substrate (Winiarska et al., 2014) . Glutathione reductase (GR) activity was determined using a previously described method, which is based on reduction of glutathione disulfide (Luchese et al., 2009) . Glutathione S-transferase (GST) activity was measured using a previously described reported method, which is based on conjugation of GSH with 1-chloro-2,4-dinitrobenzene as substrate (Habig et al., 1974) . Total glutathione (GSH) level was measured following the method of Annuk et al. (2001) . Malondialdehyde (MDA) level was measured as a marker of lipid peroxidation using the method of Chatterjee et al. (2000) , while total antioxidant capacity (TAC) was determined following the method of Koracevic et al. (2001) .
Histology of the testis for Leydig cell count
The right testis and epididymis of each rat were fixed in Bouin's solution overnight, dehydrated, and embedded in blocks of paraffin. Sections of 5 lm thickness were stained using hematoxylin and eosin (H & E) and viewed under a light microscope (Olympus BX41). Epididymal epithelial thickness was measured using image analyzer. For Leydig cell count, the number of Leydig cells in 20 random intertubular areas (area enclosed by three seminiferous tubules) was counted using 40x objective (Mohamed et al., 2011b; Nna et al., 2017b) . The mean Johnsen testicular biopsy score (MJTBS) was determined in 10 randomly selected seminiferous tubules using the method shown in Table 1 , as reported earlier (Nna et al., 2017b) .
112 Andrology, 2019, 7, 110-123 Quantitative real-time reverse transcription-polymerase chain reaction (RT-qPCR) for the quantification of mRNA transcript levels of AR, LHR, StAR, CYP11A1, CYP17A1, 3b-HSD, and 17b-HSD in the testis RNA extraction, purity, and quality assessment InnuPrep RNA mini kit (Analytik Jena, Germany) was used for RNA extraction, following the manufacturer's protocol. For each extraction, 20-30 mg of frozen testis was thawed and removed from RNAlater into lysis buffer provided in the innuPrep RNA mini kit, and homogenized using a handheld homogenizer fitted with a piston. Precipitated RNA was solubilized in diethylpyrocarbonate-treated water and stored at À80°C until use. The concentration and purity of extracted RNA were assessed using a spectrophotometer (Eppendorf Nanodrop BioPhotometer plus, UK). Samples with OD260/280 1.8-2 were considered pure. To assess the integrity of the extracted RNA, gel electrophoresis was performed using 1% agarose (w/v) in 1x LB buffer and stained with DNA gel stain. Briefly, 25 mL of 1% agarose gel was poured into a casting tray with a comb inserted and allowed to set at room temperature for 30 min, after which the gel was placed in an electrophoresis tank, with 1x LB buffer used as running buffer. Each sample (100 ng/lL; 2 lL) was mixed with 2 lL of loading dye and carefully pipetted into separate wells. DNA ladder was used as control. The electrophoresis was run for 50 min at 70 volts, after which the gel was viewed using a UV transilluminator (ChemiDoc XRS, Bio-Rad Laboratories, Hercules, CA, USA).
Samples which showed distinct 28S and 18S ribosomal RNA bands possessed the required integrity and were used for the downstream experiments.
Real-time RT-qPCR
Real-time RT-PCR was performed using SensiFAST SYBR HiRox One-Step PCR kit (Bioline, UK) with StepOnePlus Real-Time PCR system (Applied Biosystems Co., Foster City, CA, USA). Melting curve analysis was performed for each target to confirm their specificity, while standard curve was performed with the control sample to select the best concentration of template for PCR amplification, while also paying attention to primer efficiency which was > 90% for each target. The primer pairs used for this study were selected from GenBank (Table 2) and were synthesized by Integrated DNA Technologies (IDT, Malaysia). PCR amplification was performed following the manufacturer's protocol. The cycling conditions (three-step cycling) were as specified in the One-Step PCR kit and consisted of initial denaturation step of 2 min at 95°C, followed by 40 cycles of (i) denaturation for 5 sec at 95°C, (ii) annealing at 60°C for 10 sec, and (iii) extension at 72°C for 5 sec. Each sample was analyzed in triplicate, and the Livak method (2 ÀDDCt ) was used for relative quantification using GAPDH as housekeeping gene. The amplified PCR products were subjected to gel electrophoresis, and the representative images were captured for each group.
Determination of intratesticular StAR, CYP11A1, 3b-HSD and 17b-HSD activities Testicular levels of StAR protein, CYP11A1, 3b-HSD, and 17b-HSD activities were determined using ELISA kits purchased from Shanghai Qayee (China), following the manufacturer's protocol.
Statistical analysis
Data were analyzed using GRAPHPAD PRISM 7.0 for Windows (GraphPad Software Inc., La Jolla, CA, USA). One-way analysis of variance (ANOVA) was employed, followed by Tukey's post hoc test to analyze data with normal distribution and homogenous variance, and results were expressed as mean AE standard deviation (SD). Kruskal-Wallis test was employed for data with nonnormal distribution and non-homogenous variance, followed by Dunn's multiple comparison test, and results were expressed as median (interquartile range). Categorical data were analyzed using Pearson's chi-squared test and presented in percentage. A value of p < 0.05 was considered statistically significant.
RESULTS
Fasting blood glucose
Initial FBG level did not significantly differ between the experimental groups. Seventy-two hours post-STZ injection, FBG level was significantly higher (p < 0.001) in DC and D+Met groups compared to NC group. Following treatment with metformin for 4 weeks, FBG level was significantly lower (p < 0.001) in D+Met group by 2.96-fold compared to DC group. FBG level remained significantly higher (p < 0.001) in DC group by 6.65-fold, compared to the NC group, while D+Met group was 2.24-fold higher than NC group (Table 3) .
Leydig cells and epididymal epithelial height
Intertubular spaces of testis sections of rats in DC group showed decreased Leydig cell number. Leydig cell count decreased significantly (p < 0.001) in DC group compared to NC. Following intervention with metformin, there was a significant increase (p < 0.001) in Leydig cell count compared to DC group (Fig. 1A-D) . However, Leydig cell count was significantly lower (p < 0.01) in D+Met group compared to NC group (Fig. 1D ). Epididymal histology showed large areas with reduced spermatozoa densities and thickening of the epithelial layer in DC group, relative to NC and D+Met groups (Fig. 1A-C) . Epididymal epithelial height was significantly higher in DC (p < 0.001) and D+Met (p < 0.05) groups, compared to NC group, but significantly lower (p < 0.01) in D+Met group compared to DC group (Fig. 1E) .
mRNA transcript levels of androgen and luteinizing hormone receptors in the testis
The mRNA transcript levels of AR and LHR in the testis were significantly lower (p < 0.001) in DC group, compared to NC group. Following intervention with metformin, AR and LHR mRNA transcript levels were significantly higher (p < 0.05) compared to DC group. However, the mRNA transcript levels of AR and LHR were significantly lower (p < 0.01; p < 0.001) in D+Met group compared to NC group ( Fig. 2A-C) .
mRNA transcript levels of StAR and CYP11A1 in the testis
After 4 weeks of STZ-induced DM, the mRNA transcript level of StAR in the testis was significantly lower (p < 0.001) in DC group compared to NC group. Following intervention with metformin, StAR mRNA transcript level was significantly higher compared to DC (p < 0.001) and NC (p < 0.01) groups. Furthermore, CYP11A1 mRNA transcript level was significantly lower (p < 0.001) by several folds in DC group, compared to NC group. CYP11A1 mRNA transcript level was significantly higher (p < 0.001) in D+Met group compared to DC group, but was significantly lower (p < 0.001) compared to NC group (Fig. 3A-C) . mRNA transcript levels of CYP17A1, 3b-HSD, and 17b-HSD in the testis
The mRNA transcript level of CYP17A1 did not significantly differ between DC and NC groups, although it was lower in DC group. Intervention with metformin significantly increased (p < 0.001) the transcript level of CYP17A1 relative to NC and DC groups (Fig. 4A) . The mRNA transcript levels of 3b-HSD and 17b-HSD in the testis were significantly lower (p < 0.001) in DC group, compared to NC group. Metformin treatment significantly increased (p < 0.001) the mRNA transcript levels of 3b-HSD and 17b-HSD compared to DC group. There was no significant difference for transcript levels of 3b-HSD and 17b-HSD between D+Met and NC groups (Fig. 4B-D) .
Testicular levels of StAR protein, CYP11A1, 3b-HSD, and 17b-HSD Testicular levels of StAR protein, CYP11A1, 3b-HSD, and 17b-HSD decreased significantly (p < 0.001) in DC group, relative to NC group. Compared to NC group, D+Met group had significant decreases in the levels of CYP11A1 (p < 0.05), 3b-HSD (p < 0.001), and 17b-HSD (p < 0.001), but not StAR protein level (p > 0.05). Nevertheless, we observed significant increases in the levels of StAR protein, CYP11A1, 3b-HSD, and 17b-HSD in D+Met group (p < 0.001) when compared with DC group (Fig. 5A-D) .
Serum and intratesticular testosterone, LH, and FSH levels
Serum testosterone concentration was significantly lower (p < 0.01), while LH was significantly higher (p < 0.01) in DC group, compared to NC group. Although serum testosterone increased in D+Met group relative to DC group, the increase was not significant. Furthermore, serum testosterone did not significantly differ between D+Met and NC groups. Serum FSH did not significantly differ between the groups, although it was highest in DC group (Table 4) .
There was a significant decrease in intratesticular concentration of testosterone (p < 0.001) in DC group compared to NC group, while LH and FSH did not significantly differ across the groups. Following intervention with metformin, intratesticular testosterone increased significantly (p < 0.001) compared to DC group, with values near NC levels (Table 4) .
Sperm parameters
Epididymal sperm count and viability were significantly lower (p < 0.001) in DC group compared to NC group. Sperm count and viability were significantly higher (p < 0.001) in D+Met group compared to DC group, but significantly lower (p < 0.001) compared to NC group (Table 5) . Sperm motility and sperm rapid progressive forward movement (RPFM) were significantly lower (p < 0.001), while percentage of non-motile spermatozoa was significantly higher (p < 0.001) in DC group compared to NC group. Sperm motility and RPFM were significantly higher (p < 0.001), while percentage of non-motile spermatozoa was significantly lower in D+Met group, compared to DC group. However, there were significant decreases in sperm motility (p < 0.01) and RPFM (p < 0.001), and significant increase in percentage of non-motile spermatozoa (p < 0.01) in D+Met group, compared to the NC group (Table 5) . Spermatozoa with abnormal morphology increased significantly (p < 0.001) in DC group compared to NC group. Furthermore, there was a significant increase in the percentage of spermatozoa with head and tail defects (p < 0.001) in DC group, compared to NC group. Treatment with metformin significantly decreased the percentage of spermatozoa with abnormal morphology, and head and tail defects (p < 0.001). Although the percentage of spermatozoa with head and tail defects in D+Met group did not significantly differ from NC group, the percentage of spermatozoa with abnormal morphology (total defect) was significantly higher (p < 0.01) in D+Met group compared to NC group (Table 5 ). The mean Johnsen testicular biopsy score was significantly lower (p < 0.001) in DC and D+Met groups compared to NC group, but significantly higher (p < 0.001) in D+Met group compared to DC group (Table 5) .
Sperm nDNA fragmentation
The percentage of spermatozoa with fragmented nDNA increased significantly (p < 0.001) in DC group compared to NC group. Although sperm nDNA fragmentation was significantly higher (p < 0.05) in D+Met group compared to NC group, it was significantly lower (p < 0.001) compared to DC group (Fig. 6A and B).
Oxidative stress in the epididymis
Diabetic control group had significantly lower (p < 0.001) SOD and CAT activities, compared to NC group. Although SOD and CAT activities were significantly lower (p < 0.01) in D+Met group, compared to NC group, their activities were significantly higher (p < 0.001) compared to DC group (Table 6) . Similarly, the activities of GPx, GST, and GR were significantly lower (p < 0.001) in DC group, compared to NC group. GPx activity did not significantly differ between NC and D+Met groups, whereas GST and GR activities were significantly lower (p < 0.001) in D+Met group compared to NC group. However, significant increases in the activities of GPx (p < 0.001), GST (p < 0.05), and GR (p < 0.001) were observed in D+Met group compared to DC group. Total GSH level decreased significantly in DC (p < 0.001) Figure 5 Effect of metformin on the levels of StAR protein (A), CYP11A1 (B), 3b-HSD (C), and 17b-HSD (D) in the testis of diabetic rats. Values are mean AE SD, n = 6. *p < 0.05, ***p < 0.001 vs. NC; z p<0.001 vs. DC (one-way ANOVA, followed by Tukey's post hoc test). Values are mean AE SD, n = 6. *p < 0.05, **p < 0.01, ***p < 0.001 vs. NC; z p < 0.001 vs. DC (one-way ANOVA, followed by Tukey's post hoc test). and D+Met (p < 0.05) groups compared to NC group. Nevertheless, treatment with metformin increased GSH level significantly (p < 0.001) relative to DC group (Table 6) . Significantly higher (p < 0.001) MDA level and lower TAC were observed in DC and D+Met groups compared to NC group. MDA level was significantly lower (p < 0.001), and TAC was significantly higher (p < 0.001) in D+Met group, relative to DC group (Table 6) .
Fertility outcome
At the end of the study, 12 female rats (in each NC and D+Met groups) were mated, while only six female rats were mated in DC group. Significant decreases in gravid uterine weight (p < 0.001), litter size per dam (p < 0.001), and fetal weight (p < 0.01) were recorded in the DC group compared to NC group. Intervention with metformin significantly increased gravid uterine weight (p < 0.001), litter size per dam (p < 0.01), and fetal weight (p < 0.01) compared to DC group (Table 7) . Number of implantation sites decreased significantly (p < 0.05) in DC group compared to NC group, while number of corpora luteal did not significantly differ between the groups. Number of implantation sites did not significantly differ between DC and D+Met groups (Table 7) .
There were significant increases in pre-implantation (p < 0.001) and post-implantation (p < 0.01) losses in DC group compared to NC group. Following intervention with metformin, we observed significant decrease in post-implantation (p < 0.01), but not pre-implantation (p > 0.05) losses compared to DC group. Implantation losses did not significantly differ between D+Met and NC groups (Table 7) . Mating and fertility indexes decreased significantly (p < 0.05) in DC group, relative to NC group, and increased significantly (p < 0.05) in D+Met group relative to DC group, but did not significantly differ between D+Met and NC groups (Table 7) . Figure 6 Sperm nuclear DNA fragmentation using acridine orange test. Sperm smears were stained with freshly prepared acridine orange and viewed using a fluorescent microscope with 100x objective (oil immersion) and a 460-nm filter (scale bar: 20 lm). Sperm heads with green fluorescence (white arrow) indicate intact nDNA, while sperm heads with orange fluorescence (yellow arrow) indicate fragmented nDNA (A). Values are mean AE SD, n = 6 for percentage of sperm nDNA fragmentation (B). *p < 0.05, ***p < 0.001 vs. NC; z p<0.001 DC (one-way ANOVA, followed by Tukey's post hoc test). CAT, catalase; GPx, glutathione peroxidase; GR, glutathione reductase; GSH, total glutathione; GST, glutathione S-transferase; MDA, malondialdehyde; SOD, superoxide dismutase; TAC, total antioxidant capacity. Values are mean AE SD, n = 6. *p < 0.05, **p < 0.01, ***p < 0.001 vs. NC; x p < 0.05, y p < 0.01, z p < 0.001 vs. DC (one-way ANOVA, followed by Tukey's post hoc test). 
DISCUSSION
Reproductive impairment is one of the most often overlooked consequences of DM in males of reproductive age. Several reports have shown increased oxidative stress status in virtually all the tissues of the body in diabetic state. This hyperglycemia-induced oxidative stress is thought (in part) to be responsible for reproductive impairment. In the present study, we attempt to assess the mechanism involved in metformin's beneficial effect beyond modulation of oxidative stress in the testis, which had been previously reported (Rabbani et al., 2010; Ayuob et al., 2015) . We observed over fivefold increase in FBG level in DC and D+Met groups 72 h post-STZ injection, confirming successful DM induction. Thereafter, the DC group showed a persistently higher FBG level relative to NC group, throughout the study period.
To elucidate the underlying mechanism involved in steroidogenesis decline in DC group and metformin's beneficial role, we examined the mRNA transcript levels and activities of related genes. Consistent with previous observations (Pavlova et al., 2016) , we found significant decrease in Leydig cell count in the DC group relative to NC group, which may be attributed to testicular oxidative stress and apoptosis (Joshi et al., 2017) . Reduction in Leydig cell number was accompanied by suppressed steroidogenesis as seen with lower intratesticular and serum testosterone levels in DC group, which are similar with other studies on humans (Bansal et al., 2017; Rovira-Llopis et al., 2017) and animals (Hamden et al., 2010; Reddy et al., 2016; Lin et al., 2017) . In the present study, DM decreased AR and LHR transcript levels in the testis and increased the level of LH, but not FSH, in the serum. Guo et al. (2016) previously reported insignificant changes in serum levels of FSH and LH in STZinduced diabetic rats, 8 weeks post-diabetes induction. In the present study however, intratesticular levels of FSH and LH in DC group did not differ from those of NC group. We hypothesize that the increased serum LH level observed in DC group may be a compensatory mechanism, as AR and LHR were down-regulated, and testosterone level was significantly decreased. StAR and CYP11A1 mRNA transcript and protein levels decreased significantly in DC group. StAR transports cholesterol (the substrate for steroidogenesis) from the outer mitochondrial membrane into the inner mitochondrial membrane, where the first enzymatic step in steroidogenesis occurs. Worthy of note is that the rapid upsurge of steroidogenesis following copious LH release (in physiological state) is entirely dependent on the response of StAR to transport cholesterol from the outer to the inner mitochondrial membrane where CYP11A1 resides (Bremer & Miller, 2014) . For this reason, StAR and CYP11A1 both constitute the rate-limiting step in steroidogenesis. The cytochrome P450 enzyme, CYP11A1, catalyzes the synthesis of pregnenolone from cholesterol. Following decreased levels of both StAR and CYP11A1 in DC group, we hypothesize that the first enzymatic step was significantly suppressed. Previous studies reported decreased mRNA transcript (Joshi et al., 2017) and protein (Xu et al., 2014; Joshi et al., 2017 ) levels of both StAR and CYP11A1 in DM. However, Ding et al. (2016) reported decreased transcript level of CYP11A1, but not StAR. Previous studies had attributed reduced steroidogenesis in diabetic rats to the absence and/or reduced stimulatory effect of insulin on Leydig cells (Ballester et al., 2004) . On the other hand, metformin is known to improve insulin sensitivity and enhance glucose uptake. Following intervention with metformin, we observed increases in StAR and CYP11A1 mRNA transcript and protein levels, which was accompanied by a reduction in serum LH level, suggestive of its beneficial effect on steroidogenesis.
Beyond the first enzymatic step in steroidogenesis, we also observed several fold reduction in the mRNA transcript and protein levels of 3b-HSD and 17b-HSD, while CYP17A1 mRNA transcript level decreased marginally in DC group, suggestive of a suppressive effect on steroidogenesis. CYP17A1 catalyzes the synthesis of dehydroepiandrosterone (DHEA) from pregnenolone, while 3b-HSD and 17b-HSD catalyze the downstream reactions leading to the synthesis of testosterone from DHEA (Bremer & Miller, 2014) . Consistent with our findings, Ding et al. (2016) previously reported decreased transcript level of 17b-HSD, but not 3b-HSD, in diabetic rats. We hypothesize that suppression of the rate-limiting step of steroidogenesis and decreased transcript levels of genes encoding for CYP17A1, 3b-HSD, and 17b-HSD, which catalyze the downstream reactions in steroidogenesis, are responsible for the decreased serum and intratesticular levels of testosterone in the present study.
Clinical studies have reported that insulin resistance trigger contrasting effects on the male and female gonads. In females, insulin resistance (as seen in PCOS patients) directly stimulates steroidogenic enzymes (notably StAR, CYP17A1, and 3b-HSD) in the ovary, causing an increase in androgen levels (Tang et al., 2017) , while in males, insulin resistance is associated with a decrease in testosterone secretion by Leydig cells (Pitteloud et al., 2005) . Earlier reports have suggested that metformin reduces the risk of abortion in women with PCOS (Palomba et al., 2014) . Furthermore, a meta-analysis of 31 clinical trials showed that metformin supplementation could reduce serum androgen levels, improve menstrual cyclicity, and stimulate ovulation in women with PCOS (Tang et al., 2017) . These effects were attributed to the easing of excessive insulin stimulation on the ovaries, as insulin is known to directly stimulate steroidogenic enzymes in the ovaries (Tang et al., 2017) . Interestingly, in our study of STZ-induced male diabetic rats, metformin increased mRNA transcript levels of steroidogenesis-related genes, thus increasing serum and intratesticular testosterone levels. Previous studies demonstrated that persistent hyperglycemia increased mitochondrial glucose oxidation, releasing large amounts of free radicals which become harmful to cells (Roy et al., 2015) . As circulating systemic insulin does not cross the blood-testis barrier (Schoeller et al., 2012) , we hypothesize that metformin may have achieved the observed positive effect on steroidogenesis through a systemic mechanism, by decreasing hyperglycemia (the primary culprit) and its accompanying testicular oxidative damage, thus sparing steroidogenic cells.
In the present study, the effect of metformin on steroidogenesis in normoglycemic state was not considered as the medication is originally indicated for hyperglycemia and/or insulin resistance. However, some researchers have attempted to elucidate metformin's effect on steroidogenesis in normoglycemic state, using murine and human fetal testis. For example, Tartarin et al. (2012) reported a significant decrease in testosterone level in humans but not murine fetal testis cultured with the therapeutic dose of metformin (50 lm). Their report also showed significant decrease in testosterone level and Leydig cell number in the testis of murine fetus exposed to metformin in utero for 16 days (from day 0.5 to 16.5 of intra-uterine life), with no effect on germ cell apoptosis (Tartarin et al., 2012) . Furthermore, the authors reported no detrimental effect on testosterone and Leydig cells in the testis of newborn mice exposed to metformin in utero for 13 days (from day 0.5 to 13.5 of intra-uterine life) (Tartarin et al., 2012) . However, they reported several fold decreases in mRNA transcript levels of StAR, CYP11A1, CYP17A1, 3b-HSD, and LHR in murine fetal testis cultured with 5 mM metformin (100 times the therapeutic dose) for 72 h (Tartarin et al., 2012) . The significant down-regulation of steroidogenesis-related genes may be attributable to the high dose of metformin used in the abovementioned study, which employed apparently healthy murine models, as data from clinical investigations have demonstrated that administering the therapeutic dose of metformin to PCOS patients during the first trimester of pregnancy and/or throughout pregnancy had no detrimental effects on the developing fetus (Glueck et al., 2004 (Glueck et al., , 2011 . Nevertheless, more in vivo animal studies using adult models maybe necessary to clearly elucidate metformin's effect on adult male reproductive function in normoglycemic state.
Impaired spermatogenesis was evident in DC group. We found significant decreases in sperm count, motility, viability, and normal morphology, which are consistent with previous studies (Ding et al., 2016) . Also, Johnsen's score, which is a measure of the degree of spermatogenesis, was significantly lower in DC group, relative to NC group. Epididymal histology revealed large areas with low spermatozoa density, validating the sperm count data. We also observed an increase in sperm nDNA fragmentation in DC group. Studies have linked spermatogenesis impairment in diabetic state with impaired testicular energy metabolism (Alves et al., 2013) , increased testicular oxidative stress (Kanter et al., 2012) , and increased germ cell apoptosis (Rashid & Sil, 2015) , occasioned by persistent hyperglycemia. Beyond these, we hypothesize that decreased transcript levels of AR, LHR, and steroidogenesis-related genes are major contributory factors, as spermatogenesis depends largely on testosterone. To assess the health of spermatozoa beyond the testis, we examined markers of oxidative stress in the epididymis. Significantly decreased antioxidant enzymes (SOD, CAT, GPx, GST, and GR), increased lipid peroxidation (MDA), and decreased total antioxidant capacity found in DC group indicated the presence of oxidative stress in the epididymis. Consequently, surviving spermatozoa from the testis may still be at risk of oxidative damage during storage in the epididymis. In the present study, treatment with metformin improved sperm count, viability, motility, normal morphology, Johnsen's score, and reduced sperm nDNA fragmentation. These observations may be attributable to improved testosterone synthesis, reduced testicular oxidative damage (Rabbani et al., 2010) , and reduced epididymal oxidative stress as a result of decreased hyperglycemia, which is the primary culprit.
We found significant impairment in fertility outcome in DC group as determined by mating and fertility indexes. We only recorded six successful mating in DC group out of 12, while all six male rats in NC and D+Met groups recorded two successful mating each (totalling 12 successful mating each for NC and Figure 7 Schematic representation of the effect of metformin on diabetes-induced fertility decline in male rats. Binding of LH to its receptor on the membrane of the Leydig cell releases protein kinase A (PKA). PKA then promotes the expression of steroidogenesis-related genes to boost androgen production. In the DC group in the present study, LHR was down-regulated, resulting in decreases in the activities of steroidogenesis-related genes, testosterone level, spermatogenesis, and fertility potential. Metformin up-regulated LHR and AR, as well as steroidogenesis-related genes, leading to increased testosterone level and improved spermatogenesis and fertility. Metformin achieved these effects by modulating blood glucose level, thus decreasing oxidative stress and its accompanying testicular damage. Red arrows represent DM-induced down-regulation, while green fonts represent parameters that were improved following metformin treatment.
120 Andrology, 2019, 7, 110-123 D+Met groups). The decrease in mating and fertility indexes in DC group has a direct link with testosterone level. Both human (Hackett et al., 2017) and experimental (Shi et al., 2017; Yang et al., 2017 ) studies have reported decreased testosterone level and suppressed sexual function in diabetic state. Testosterone replacement therapy in diabetic males significantly improves sexual appetite and erectile function (Hackett et al., 2016 (Hackett et al., , 2017 , thus suggesting the importance of testosterone in male fertility. Litter size, gravid uterine weight, fetal weight, and number of implantation sites were significantly lower in DC group compared to NC group. Decreased gravid uterine weight recorded in DC group may be attributable to decreased litter size as both correlate positively. The decreased litter size, fetal weight, and number of implantation sites, and increased pre-and postimplantation loses may be attributable to the poor spermatozoa quality of rats in DC group. Clinical studies have reported low birthweights of infants born to diabetic fathers (Hillman et al., 2013; Moss & Harris, 2015) , thus suggesting the importance of pre-copulatory health of expectant fathers. Although metformin did not reduce the blood glucose level of diabetic rats to NC levels, we observed a 2.96-fold decrease relative to DC group. Therefore, improvement in fertility outcome following metformin administration in the present study may be attributable to its effect on glycemic control, which consequently improved testosterone biosynthesis and sperm quality (Fig. 7) .
CONCLUSION
Diabetes mellitus results in significant reproductive impairment and decreased fertility potential, which may be attributable to decline in testosterone biosynthesis and poor sperm quality. Treatment with metformin improved fertility potential of male diabetic rats. This improvement may be attributed to stimulation of the rate-limiting step of steroidogenesis as well as increased testicular levels of CYP17A1, 3b-HSD, and 17b-HSD. Therefore, metformin is a potentially beneficial medication in preserving male fertility in diabetic state.
